|
[Related PubMed/MEDLINE]
Total Number of Papers: 207
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: TRAb |
| Long Form |
: thyrotropin receptor antibody |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
A retrospective study of clinical features and prognosis of patients with Graves' disease and ophthalmopathy. |
GD |
| 2 |
2023 |
Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study. |
AITD, ALZ, ATDs, GD, HT, MS, RR |
| 3 |
2022 |
Change of intraocular blood flow during treatment for thyroid eye disease. |
CAS, LSFG, OCTA, TED |
| 4 |
2022 |
Consistency Between Thyrotropin Receptor Antibody (TRAb) and Thyroid-Stimulating Antibody (TSAb) Levels in Patients with Graves Disease. |
GD, TSAb |
| 5 |
2022 |
Coronavirus as a Trigger Of Graves' Disease. |
--- |
| 6 |
2022 |
Decreased serum interleukin-41/Metrnl levels in patients with Graves' disease. |
CRP, FT3, FT4, GD, IL, TgAb, TPOAb, TSH, WBC |
| 7 |
2022 |
Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves' Ophthalmopathy. |
GD, GO, OFs, Th17 |
| 8 |
2022 |
Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism. |
ATD, CeH, GD |
| 9 |
2022 |
Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report. |
CT |
| 10 |
2022 |
Outcomes of Early-Pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-Up Study. |
ATDs, OR |
| 11 |
2022 |
Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review. |
GH, IGF-1, MRI, PitNETs, PRL, SRL, TgAb, TPOAb, TSH |
| 12 |
2022 |
Severe Hyperthyroidism and Complete Hydatidiform Mole in Perimenopausal Woman: Case Report and Literature Review. |
GTD |
| 13 |
2022 |
The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease. |
AIDs, COVID-19, GD, SARS-CoV-2 |
| 14 |
2022 |
The Interactive Effects of Severe Vitamin D Deficiency and Iodine Nutrition Status on the Risk of Thyroid Disorder in Pregnant Women. |
CI, UIC |
| 15 |
2022 |
Utility of Antibodies in the Diagnoses of Thyroid Diseases: A Review Article. |
Anti-TPO antibodies, CTLA, GD, HLA, HT, TPO, TSGT |
| 16 |
2022 |
Xiehuo Xiaoying decoction inhibits Tfh cell expansion and promotes Tfr cell amplification to ameliorate Graves' disease. |
FOXP3, GD, HO-1, Keap1, Nrf2, OS, XHXY |
| 17 |
2022 |
[Analysis of experience in diagnosis and treatment of fetal goiter in patients with Graves' disease complicated with pregnancy]. |
GD |
| 18 |
2021 |
A Chinese survey on clinical practice in hyperthyroidism management: comparison with recent studies and guidelines. |
ATA, ATDs, RAIU |
| 19 |
2021 |
A Longitudinal Study of Medial Temporal Lobe Volumes in Graves Disease. |
GD, MR, MTL |
| 20 |
2021 |
A systematic review of euthyroid Graves' disease (Review). |
EGD |
| 21 |
2021 |
Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease. |
GD |
| 22 |
2021 |
Autoimmune thyroid disease correlates to islet autoimmunity on zinc transporter 8 autoantibody. |
AITD, GADA, GD, HC, HT, IA-2A, T1DM, TgAb, TPOAb, ZnT8A |
| 23 |
2021 |
Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy. |
BCVA, DON, ROC, SPECT/CT, TED, UR, VACI, VEP |
| 24 |
2021 |
Correlation between thyroid autoantibodies and cardiovascular disease in patients with stages 3-5 chronic kidney disease. |
CKD, CVD, TPOAb |
| 25 |
2021 |
Effects of animal protein intake during pregnancy on autoimmune thyroiditis in pregnant women with mild iodine deficiency. |
CI, TPOAb, UIC |
| 26 |
2021 |
Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves' disease. |
GD, MPT, TgAb, TPOAb |
| 27 |
2021 |
Evaluation of choroidal circulation and stromal features in Graves' disease. |
CT, CVI, GD, SA, TCA |
| 28 |
2021 |
Evaluation of thyroid disease and thyroid malignancy in acromegalic patients. |
FNAC, GH, IGF, MNG, OR, US |
| 29 |
2021 |
Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease. |
GD |
| 30 |
2021 |
Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease. |
AF, BMI, GD, HF, HFpEF, HFrEF |
| 31 |
2021 |
Possibility analysis of thyroid imaging parameters for dose adjustment in 131I treatment of hyperthyroidism. |
ROI |
| 32 |
2021 |
Probiotic Bifidobacterium longum supplied with methimazole improved the thyroid function of Graves' disease patients through the gut-thyroid axis. |
GD |
| 33 |
2021 |
Risk factors for Graves' Orbitopathy in surgical patients-Results of a 10-year retrospective study with review of the literature. |
GD, GO, TPOAb |
| 34 |
2021 |
Steroid-Resistant Graves' Orbitopathy Treated with Tocilizumab in Real-World Clinical Practice: A 9-Year Single-Center Experience. |
CAS, GO |
| 35 |
2021 |
The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease. |
AITDs, GD, RAI, TBAb, TPOAb, TSAb |
| 36 |
2021 |
THYROTROPIN-RECEPTOR ANTIBODIES, IMMUNOGLOBULIN E AND ANTINUCLEAR ANTIBODIES IN PATIENTS WITH GRAVES' DISEASE AND GRAVES' ORBITOPATHY. |
ANA, GD, GO, HC, IgE, TBII |
| 37 |
2020 |
Basedow's disease with associated features of Hashimoto's thyroiditis based on histopathological findings. |
TgAb, TPOAb, TSAb |
| 38 |
2020 |
Clinical features and predictors of remission in children under the age of 7 years with Graves' disease. |
GD, TPOAb |
| 39 |
2020 |
Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature. |
GD, TSH |
| 40 |
2020 |
Elevated Immunoglobulin G4 Levels in Patients with Thyroid Eye Disease and Their Clinical Implications. |
BCVA, CAS, IgG4, TED |
| 41 |
2020 |
Factors associated with severity of orbitopathy in patients with Graves' disease. |
CAS, GD, GO, IOP, ULN |
| 42 |
2020 |
Impact of Radioiodine Treatment on Doppler Flow Parameters in the Central Retinal Artery and Ophthalmic Artery in Patients With Hyperthyroidism. |
CRA, EDV, OA, RI |
| 43 |
2020 |
Measurement of anti-TSH receptor antibodies: what is the correct cut-off value? |
--- |
| 44 |
2020 |
Preoperative plasmapheresis experience in Graves' disease patients with anti-thyroid drug-induced hepatotoxicity. |
ATI, TPE |
| 45 |
2020 |
Scintigraphy evaluation of hyperthyroidism and its correlation with clinical and biochemical profiles. |
--- |
| 46 |
2020 |
Serum concentrations of TNF-alpha and its soluble receptors in Graves' disease. |
GD, sTNFRs, TNF-alpha, TSH |
| 47 |
2020 |
Significant cardiac disease complicating Graves' disease in previously healthy young adults. |
AF, HF |
| 48 |
2020 |
The Potential Link between Gut Microbiota and Serum TRAb in Chinese Patients with Severe and Active Graves' Orbitopathy. |
GO, OTUs |
| 49 |
2020 |
The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor. |
hs-CRP, MAFLD, TgAb, THs, TPOAb, TSH |
| 50 |
2020 |
THYROID ACROPACHY: A RARE MANIFESTATION OF GRAVES DISEASE IN JOINTS. |
FT4, GD, TSH |
| 51 |
2020 |
[Application of the superior thyroid artery peak systolic velocity in differentiating Graves' disease from autoimmune thyroiditis]. |
AIT, AUC, GD, ROC, STA-PSV |
| 52 |
2019 |
A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease |
GD, MMI, Se, TgAb, TPOAb |
| 53 |
2019 |
Evaluation of Vitamin D Status and its Impact on Thyroid Related Parameters in New Onset Graves' Disease- A Cross-sectional Observational Study. |
OR, PTH, TSH, VDD |
| 54 |
2019 |
Severe unilateral orbitopathy in a patient with Hashimoto's thyroiditis - a case report. |
CAS, GD, HT, MRI, TAO |
| 55 |
2018 |
A patient-specific treatment model for Graves' hyperthyroidism. |
MMI, TSH |
| 56 |
2018 |
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease. |
EGD, TAO, TBII, TSAb |
| 57 |
2018 |
Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis. |
CAS, GRADE, IL-6, NOS, RTX, SMD, TAO, TSH |
| 58 |
2018 |
Elevated Interleukin-36alpha And CD4+IL-36alpha+T Cells Are Involved in the Pathogenesis of Graves' Disease. |
ELISA, GD, NC, PBMCs, qRT-PCR |
| 59 |
2018 |
Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls. |
EBV, IgG, IgM, PBMCs |
| 60 |
2018 |
Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy. |
GD, NH, RAI |
| 61 |
2018 |
Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review. |
--- |
| 62 |
2018 |
Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis. |
RAI, TED |
| 63 |
2018 |
Prediction of Neonatal Hyperthyroidism. |
TSH |
| 64 |
2018 |
Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy. |
GD, TED |
| 65 |
2018 |
Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions. |
ADRs, ATDs, GD |
| 66 |
2018 |
Thyrotropin receptor antibody: A novel risk indicator for pregnancy loss. |
ROC, TSH |
| 67 |
2018 |
Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics. |
DBP, GD, GO, SNPs, VDR |
| 68 |
2018 |
[Atypical subacute thyroiditis in combination with Grave's disease:Diagnostic difficulties in a case report]. |
--- |
| 69 |
2017 |
DYNAMIC CHANGES OF TRAb AND TPOAb AFTER RADIOIODINE THERAPY IN GRAVES' DISEASE. |
GD, RAI, TPOAb, TSH |
| 70 |
2017 |
Optimal iodine supplementation during antithyroid drug therapy for Graves' disease is associated with lower recurrence rates than iodine restriction. |
ATD, FT3, FT4, GD, UIC |
| 71 |
2017 |
Risk Factors Associated with the Activity and Severity of Graves' Ophthalmopathy among Patients at the University of the Philippines Manila-Philippine General Hospital. |
GD, GO, UIE |
| 72 |
2017 |
Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment. |
ALP |
| 73 |
2017 |
Role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in autoimmune thyroid disease. |
AITD, Fn14, GD, HCs, HT, PBMCs, sCD163, sTWEAK, TWEAK, TWEAK |
| 74 |
2017 |
Serum miR-146a, miR-155, and miR-210 as potential markers of Graves' disease. |
AUC, GD |
| 75 |
2017 |
The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease. |
CTLA-4, GD, Treg, TSHR |
| 76 |
2016 |
Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy. |
GD, GO, RTX |
| 77 |
2016 |
Common phenotype and different non-HLA genes in Graves' disease and alopecia areata. |
AA, GD |
| 78 |
2016 |
Does Immunosuppressive Therapy Improve Outcomes in Graves' Disease? A Systematic Review and Meta-Analysis. |
CI |
| 79 |
2016 |
Graves' disease in 2.5 years old girl - 6-years-long observation. |
--- |
| 80 |
2016 |
Irisin and Myostatin Levels in Patients with Graves' Disease. |
BMI, GD, TSH |
| 81 |
2016 |
Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China. |
BTD, HT, PTC, TgAb |
| 82 |
2016 |
Predicting relapse of Graves' disease following treatment with antithyroid drugs. |
FT, GD |
| 83 |
2016 |
Risk Factors of Lymphnode Metastasis in Patients with Thyroid Papillary Carcinoma Associated with Graves Disease. |
--- |
| 84 |
2016 |
Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy. |
CAS, IVMP, TAO |
| 85 |
2016 |
Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation. |
EBV, TRAbs |
| 86 |
2016 |
Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease. |
ATD, TBII, TSAb |
| 87 |
2015 |
Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease. |
GD, GO, PBMC, TSH |
| 88 |
2015 |
Correlation between single nucleotide polymorphism of FCRL-3 gene and Graves' disease in Han population of northern Anhui province, China. |
GD, SNP, TgAb, TPOAb |
| 89 |
2015 |
Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters. |
ADC, DWI, GD, NPV, PPV, PT, RAIU, ROC |
| 90 |
2015 |
IGF1 deficiency in newly diagnosed Graves' disease patients. |
ATA, GD, GO, TPOAb |
| 91 |
2015 |
Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease. |
GO |
| 92 |
2015 |
[Effect of Jiakangning Capsule on Thyroid Function and Akt/mTOR Signal Pathway of Graves' Disease Mice: an Experimental Study]. |
GD, JC, mTOR, p-mTOR, TSH |
| 93 |
2014 |
Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves' disease. |
GD, HDF, NHF |
| 94 |
2014 |
Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. |
ELISA, GD, HC, IL-37, PBMCs, RT-PCR |
| 95 |
2014 |
Long-term outcomes of pediatric Graves' disease. |
ATDs, GD |
| 96 |
2014 |
Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease. |
GD, PTH, TgAb, TPOAb, TSH |
| 97 |
2014 |
Management of neonates born to women with Graves' disease: a cohort study. |
ATD, GD, ve |
| 98 |
2014 |
Risk factors of hyperthyroidism with hepatic function injury: a 4-year retrospective study. |
GD, sTSH, TgAb |
| 99 |
2014 |
The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. |
AITD, Gc, GD, HD, PCR-RFLP, VDR |
| 100 |
2014 |
Therapeutic effectiveness of potassium iodine in drug-naive patients with Graves' disease: a single-center experience. |
MMI, PS |
|
A Search Service for Abbreviation / Long Form
